New research suggests that people taking GLP-1 therapy are less likely to die from colorectal cancer. Ozempic, the cancer ...

The maker of the weight-loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of these blockbuster ...

GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long ...

New research indicates Ozempic and Mounjaro offer significant cardiovascular benefits beyond weight loss and blood sugar ...

In a significant leap for gene therapy, scientists have discovered a method to reprogram the pancreas to produce GLP-1 ...

New research from the Technical University of Munich and Harvard Medical School reveals that popular GLP-1-based drugs, ...

Glucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have gained popularity globally, not just for managing type 2 diabetes but also due to ...

Scientists have known that obesity and metabolic dysfunction can make cancers more aggressive. Tumors thrive in bodies ...

Americans are going to get a little healthier. President Trump cut deals with the drugmakers Eli Lilly and Novo Nordisk to increase access to obesity drugs in a major benefit to American public health ...

This article was reviewed by Darragh O’Carroll, MD. Semaglutide Side Effects: What to Know Key takeaways: Common semaglutide ...